Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,856 | 4 | 52.2% |
| Travel and Lodging | $2,928 | 18 | 22.3% |
| Consulting Fee | $2,810 | 1 | 21.4% |
| Food and Beverage | $529.32 | 13 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sanofi Pasteur Inc. | $9,086 | 27 | $0 (2018) |
| Gilead Sciences Inc | $3,955 | 6 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $32.63 | 1 | $0 (2017) |
| Melinta Therapeutics, Inc. | $27.50 | 1 | $0 (2018) |
| The Medicines Company | $22.75 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $6,045 | 19 | Sanofi Pasteur Inc. ($6,017) |
| 2017 | $7,079 | 17 | Gilead Sciences Inc ($3,955) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2018 | Melinta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $27.50 | General |
| 06/16/2018 | Sanofi Pasteur Inc. | FLUBLOK QUADRIVALENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $345.00 | General |
| Category: VACCINES | ||||||
| 03/29/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,953.00 | General |
| Category: VACCINES | ||||||
| 03/29/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug) | Travel and Lodging | In-kind items and services | $364.00 | General |
| Category: VACCINES | ||||||
| 03/29/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug) | Travel and Lodging | Cash or cash equivalent | $166.79 | General |
| Category: VACCINES | ||||||
| 03/29/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug), FLUZONE QUADRIVALENT | Food and Beverage | In-kind items and services | $99.70 | General |
| Category: VACCINES | ||||||
| 03/29/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug) | Food and Beverage | Cash or cash equivalent | $32.36 | General |
| Category: VACCINES | ||||||
| 03/29/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug) | Travel and Lodging | Cash or cash equivalent | $30.00 | General |
| Category: VACCINES | ||||||
| 03/29/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug) | Travel and Lodging | Cash or cash equivalent | $19.24 | General |
| Category: VACCINES | ||||||
| 03/29/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug) | Travel and Lodging | Cash or cash equivalent | $15.26 | General |
| Category: VACCINES | ||||||
| 01/30/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,279.00 | General |
| Category: VACCINES | ||||||
| 01/30/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug) | Travel and Lodging | Cash or cash equivalent | $239.14 | General |
| Category: VACCINES | ||||||
| 01/30/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug) | Travel and Lodging | In-kind items and services | $202.60 | General |
| Category: VACCINES | ||||||
| 01/30/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug), FLUZONE QUADRIVALENT | Food and Beverage | In-kind items and services | $141.01 | General |
| Category: VACCINES | ||||||
| 01/30/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug) | Travel and Lodging | Cash or cash equivalent | $41.60 | General |
| Category: VACCINES | ||||||
| 01/30/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug) | Food and Beverage | Cash or cash equivalent | $27.50 | General |
| Category: VACCINES | ||||||
| 01/30/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug) | Travel and Lodging | Cash or cash equivalent | $27.00 | General |
| Category: VACCINES | ||||||
| 01/30/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug) | Travel and Lodging | Cash or cash equivalent | $15.80 | General |
| Category: VACCINES | ||||||
| 01/17/2018 | Sanofi Pasteur Inc. | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| 05/24/2017 | The Medicines Company | ORBACTIV (Drug), VABOMERE | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/19/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/18/2017 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,279.00 | General |
| Category: VACCINES | ||||||
| 05/18/2017 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug) | Travel and Lodging | In-kind items and services | $446.97 | General |
| Category: VACCINES | ||||||
| 05/18/2017 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug) | Travel and Lodging | Cash or cash equivalent | $131.54 | General |
| Category: VACCINES | ||||||
| 05/18/2017 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug), FLUZONE | Food and Beverage | In-kind items and services | $61.70 | General |
| Category: VACCINES | ||||||
About Dr. Paul Sehdev, MD
Dr. Paul Sehdev, MD is a Infectious Disease healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689607202.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Sehdev, MD has received a total of $13,123 in payments from pharmaceutical and medical device companies, with $6,045 received in 2018. These payments were reported across 36 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($6,856).
Practice Information
- Specialty Infectious Disease
- Location Portland, OR
- Active Since 07/08/2006
- Last Updated 10/23/2012
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1689607202
Products in Payments
- FLUZONE HIGH-DOSE (Drug) $8,701
- FLUBLOK QUADRIVALENT (Drug) $345.00
- NO PRODUCT DISCUSSED (Drug) $40.00
- ZERBAXA (Drug) $32.63
- ORBACTIV (Drug) $22.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Portland
Kevin Winthrop, Md, MD
Infectious Disease — Payments: $2.7M
Wendi Drummond, D.o, D.O
Infectious Disease — Payments: $127,524
Mr. David Gilbert, Md, MD
Infectious Disease — Payments: $27,605
Kieren Marr
Infectious Disease — Payments: $18,569
Dr. Phil Alday, Md, Phd, MD, PHD
Infectious Disease — Payments: $8,943
Sunwen Chou, Md, MD
Infectious Disease — Payments: $1,817